The DOI matches its Crossref record; 50 of the 54 references it cites were found in a registry or an index.
A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes
Open accessAbstract
Background: To assess T-cell exhaustion mediated by programmed cell death 1 (PD-1) pathway in patients living with type 2 diabetes (T2D). Methods: MEDLINE and ProQuest electronic databases were searched for eligible studies from inception up to February 2020. The risk of bias and the quality of evidence were independently assessed by two reviewers using the modified Newcastle-Ottawa Scale adapted for cross-sectional studies and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool, respectively. The random effects model was used to calculate effect estimates. Results: We identified 5 studies involving 380 participants which met the inclusion criteria. The pooled estimates showed elevated T helper cell exhaustion in patients with T2D in comparison to controls (mean difference [MD]: 2.57% [95% confidence interval [CI]: –3.84, 8.97]; I 2 = 100%, P < .00001). Likewise, T2D patients had increased levels of cytotoxic T-cells exhaustion (MD: 3.09% [95% CI: –12.96, 19.14]; I 2 = 100%, P < .00001). Although the upregulation of PD-1 on T-cells did not affect glucose metabolism-related profiles, it was associated with inflammation and the development of cardiovascular disease. Conclusion: In patients living with T2D, immune dysfunction is at least in part due to T-cell exhaustion mediated by the upregulation of PD-1 expression. Therefore, the use of immune checkpoint inhibitors as a therapeutic strategy may be beneficial in restoring immune function in patients with T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Of the various immunosuppressive agents, belatacept1582,1583 appears to be the least diabetogenic and tacrolimus having the highest risk for PTDM.1584–1590”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1590]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Use of antithymocyte globulin, belatacept, and minimization or elimination of tacrolimus in the immunosuppressive regimen has been shown to reduce hyperglycemia and new onset PTDM.1590,1615,1616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1590]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148 · cited 1×
“Cohen kappa scores were used to measure interrater reliability.([23]) The mean and standard deviation for each continuous effect measure was extracted or calculated using Hozo et al([24]) method.”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · cited 1×
“This systematic review and meta-analysis was prepared according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.([20]) This study forms part of the registered protocol with the International prospective register of systematic reviews (PROSPERO), registration number: CRD420…”
MethodEstimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · cited 1×
“The same reviewers evaluated the quality of evidence using the Grading of Recommendations Assessment Development and Evaluation (GRADE) approach.([22])”
MethodWherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062 · cited 2×
“Therefore, in addition to the well-described chronic antigen stimulation and inflammation in T-cell exhaustion,([7]) increased expression of PD-1 and loss of effector function is also influenced by cellular glucose metabolism.”
BackgroundPosttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204 · cited 1×
“For instance, exposure of murine T-cells to galactose or glucose substrates has been shown to enhance the expression of PD-1 in addition to increasing oxidative phosphorylation.([42]) These findings suggest that PD-1 may play a significant role in regulating cellular metabolism, or could impact energy generating mecha…”
BackgroundThe function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Sharpe, A. H., Wherry, E. J., Ahmed, R., & Freeman, G. J. (2007) · Nature Immunology · doi:10.1038/ni1443 · Cited by 1,528 · cited 1×
“PD-1 is a receptor belonging to the CD28 family that delivers a negative signal upon interacting with its two ligands, programmed death ligand 1 or 2 (PD-L1 or PD-L2).([10,30]) Successful”
BackgroundRole of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Jiang, X., Wang, J., Deng, X., Xiong, F., Ge, J., Xiang, B., Wu, X., Ma, J., Zhou, M., Li, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0928-4 · Cited by 1,457 · cited 1×
“The activation of PD-1 signaling pathway dephosphorylates TCR signaling and zeta-chain-associated protein kinase (ZAP)70 by recruiting Src homology phosphatase (SHP)-1/2 which results in the dysregulation of a number of molecular mechanisms including; the insulin-dependent phosphoinositide 3-kinase/ protein kinase B (…”
BackgroundInflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes
Pickup, J. C. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.813 · Cited by 1,414 · cited 1×
“This can lead to an exacerbated activation of both the innate and adaptive immune systems.([5]) In fact, immune responses mediated by T-cells play a pivotal role in maintaining immune homeostasis.”
Background
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Gronich, N., Maman, D., Stein, N., & Saliba, W. (2022) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00661-0 · Cited by 46
Ito, M., Iwama, S., Sugiyama, D., Yasuda, Y., Okuji, T., Kobayashi, T., Zhou, X. M., Yamagami, A., Onoue, T., Miyata, T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33049-7 · Cited by 5
Luo, J., Chen, K., & Nong, X. (2025) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2024.2444953 · Cited by 3
“Recent studies suggest a bidirectional regulatory relationship between t2DM and t lymphocytes (cD4 + t and cD8 + t cells) during disease initiation and progression, with inflammatory and anti-inflammatory cytokines acting as key mediators [10–12].”
Chevalier, G., Udovin, L., Losada, M. E. O., Bordet, S., Perez‐Lloret, S., & Capani, F. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1635201 · Cited by 1
Metadata
- Authors
- Nyambuya, T. M., Dludla, P. V., Mxinwa, V., & Nkambule, B. B.
- Affiliations
- Namibia University of Science and Technology (NA)
- South African Medical Research Council (ZA)
- University of KwaZulu-Natal (ZA)
- Corresponding author
- Nyambuya, Tawanda Maurice
- Venue
- Medicine
- Published
- 2021-04-16
- Volume
- 100
- Issue
- 15
- Pages
- e25488
- ISSN
- 0025-7974 (ISSN-L)
- 1536-5964
- PMC
- PMC8052060
- OpenAlex
- W3153913656
- Cited by
- 6
- References
- 54
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 2
- FWCI
- 0.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Medicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Fogarty International Center (D43TW010131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, PD-1, PDCD1, T cell exhaustion, T helper cells, cytotoxic T lymphocytes, immune dysfunction, inflammation, cardiovascular disease, immune checkpoint inhibitors, glucose metabolism
- MeSH terms
- Adult, Aged, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Humans, Immunity, Cellular, Male, Middle Aged, T-Lymphocytes, Signal Transduction, Up-Regulation, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes. https://app.cochat.ai/papers/10.1097/md.0000000000025488
- The paper
- Nyambuya, T. M., Dludla, P. V., Mxinwa, V., & Nkambule, B. B. (2021). A systematic review and meta-analysis on the regulation of programmed cell death-1 on T-cells in type 2 diabetes. Medicine. https://doi.org/10.1097/md.0000000000025488
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.